Cyclacel Pharmaceuticals Inc. Blog | Talkmarkets | Page 1
No data available
No data available

People who follow this stock (35)

Latest Posts

About This Stock More About This Stock
E Shares Of Cyclacel Pharmaceuticals Drop 75% After Phase 3 Trial News
Article By: Terry Chrisomalis
Wednesday, December 17, 2014 8:19 PM EDT
The 75% drop was due to the fact that the DSMB stated that the company's drug would not reach its primary endpoint of survival after an interim data analysis.
In this article: CYCC
Read

PARTNER HEADLINES

Latest Tweets for $CYCC

No tweets yet!